あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/09/30 | 日証協 | 303,865株 | -6.63% | 27,973株 | -48.14% | 547,186株 | -9.39% | 60,710株 | +83.33% |
2016/09/23 | 日証協 | 325,435株 | +4.05% | 53,941株 | +31.2% | 603,866株 | -0.16% | 33,115株 | -57.87% |
2016/09/16 | 日証協 | 312,779株 | +3.36% | 41,115株 | -43.67% | 604,810株 | -0.25% | 78,597株 | +77.83% |
2016/09/09 | 日証協 | 302,611株 | -0.87% | 72,992株 | +54.31% | 606,342株 | -8.24% | 44,198株 | +809.42% |
2016/09/02 | 日証協 | 305,255株 | -3.38% | 47,303株 | -47.63% | 660,826株 | -3.57% | 4,860株 | -89.1% |
2016/08/26 | 日証協 | 315,928株 | +7.83% | 90,322株 | +96.78% | 685,275株 | +6.67% | 44,600株 | -27.96% |
2016/08/19 | 日証協 | 292,979株 | -0.51% | 45,900株 | -63.46% | 642,426株 | +1.77% | 61,910株 | +42.32% |
2016/08/12 | 日証協 | 294,479株 | -8.39% | 125,600株 | +11% | 631,250株 | +0.34% | 43,500株 | -18.69% |
2016/08/05 | 日証協 | 321,455株 | -3.19% | 113,152株 | -63.77% | 629,126株 | -1.54% | 53,500株 | -47.38% |
2016/07/29 | 日証協 | 332,055株 | +6.61% | 312,303株 | +557.81% | 638,966株 | +1.83% | 101,670株 | +916.7% |
2016/07/22 | 日証協 | 311,455株 | +7.04% | 47,476株 | -31.32% | 627,466株 | +2.12% | 10,000株 | -68.45% |
2016/07/15 | 日証協 | 290,979株 | -3.09% | 69,124株 | +3.79% | 614,466株 | -0.76% | 31,700株 | -23.39% |
2016/07/08 | 日証協 | 300,256株 | -13.76% | 66,601株 | +19.36% | 619,167株 | -5.45% | 41,378株 | -26.7% |
2016/07/01 | 日証協 | 348,169株 | -6% | 55,800株 | -68.68% | 654,855株 | -1.72% | 56,450株 | -14.27% |
2016/06/24 | 日証協 | 370,394株 | -10.3% | 178,176株 | -37.94% | 666,305株 | +0.85% | 65,850株 | -42.46% |
2016/06/17 | 日証協 | 412,918株 | -0.89% | 287,121株 | +29.11% | 660,705株 | +2.42% | 114,450株 | -23.7% |
2016/06/10 | 日証協 | 416,619株 | +10.63% | 222,380株 | -54.77% | 645,065株 | +7.86% | 150,000株 | -59.49% |
2016/06/03 | 日証協 | 376,574株 | -23.46% | 491,710株 | -28.55% | 598,035株 | +10.76% | 370,285株 | +38.89% |
2016/05/27 | 日証協 | 491,994株 | +50.22% | 688,143株 | +278.66% | 539,917株 | +14.52% | 266,600株 | +226.32% |
※株式分割は考慮していませんのでご注意ください。
Page Top